Vanessa Carle insider trades
Open-market stock purchases and sales by Vanessa Carle, Secretary at Lexaria Bioscience Corp, from SEC Form 4 filings since Apr 26, 2021.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -30%.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- LEXX Lexaria Bioscience Corp: 1 buy, 1 sale, last Jul 29, 2025